TOXOPLASMA SEROPREVALANCE IN NORTHERN IRELAND

Editor,
Toxoplasma gondii is the causal agent of toxoplasmosis, a common parasitic infection of humans acquired either by ingestion of oocysts voided in cat faeces or tissue cysts in undercooked meat. In humans, infection is mainly asymptomatic or accompanied by mild self-limiting symptoms. Infection or reactivation in immunocompromised patients can have serious clinical consequences. Primary infection in pregnancy can lead to miscarriage, stillbirth or congenital toxoplasmosis. The majority of infected neonates do not have detectable disease at birth but carry a significant risk of developing ocular disease in later life. Historically, Northern Ireland has been considered and cited as the area with the highest toxoplasma seroprevalence in the UK at 40% in blood donors 1 , 36% in diagnostic samples 2 and even higher seroprevalence rates in farmers in Northern Ireland of 73.5% 3 However all this data actually relates to samples tested several decades ago. There has been no data in the literature on toxoplasma seroloprevalence in Northern Ireland population for more recent decades. The impression within our laboratory is that the seroprevalence rate has fallen dramatically and was now more in line with rest of UK. We set out to determine if this was the case.
Materials and Methods
A convenience set of 5787 samples received from January 2012 until September 2015 were tested routinely for Toxoplasma gondii IgG using either Vidas Toxoplasma IgG II assay (bioMérieux UK Ltd, Basingstoke, England) or Elecsys Toxo IgG (Roche Diagnostics, Rotkreuz, Switzerland)). Equivocal results were regarded as seronegative for purposes of analysis.
Results
Of 5787 sera tested, 16.07% were seropositive but there was a marked reduction in seroprevalence with younger age (table 1 and figure 1) . A total of 85% of samples from patients born between 1920 and 1929 were seropositive contrasting with 6% for patients born between 1990 and 1999.
Discussion
The most likely interpretation of this data is an age cohort effect suggesting that acquisition in childhood has decreased greatly over the past 50 years. It should be noted that the vast majority of the samples in the post-2010 DOB group were from babies and thus reflect maternal seroprevalence (similar to age cohorts 2 decades previously), hence explaining the slight apparent upward trend in this group.
Other countries such as France with previously reported high seroprevalence rates have seen marked decreases in seroprevalence 4 . It is likely that such decreases in toxoplasma seroprevalence are due to changes in animal husbandry and food exposure. Knowledge of current seroprevalence is important for understanding the epidemiology and determining approaches to congenital toxoplasmosis in Northern Ireland and similar countries. 
WHY ASTHMA STILL KILLS
Editor,
In May 2014, the RCP National Review of asthma deaths was published, entitled "Why asthma still kills"¹. The report reviewed asthma deaths in the four UK countries over a 12 month period. One recommendation was that all asthma patients who have been prescribed more than 12 short acting beta agonist (SABA) reliever inhalers in the previous 12 months should be invited for urgent review of their asthma control².
Following on from this report, I conducted an audit of SABA overuse in asthmatics in a GP practice in West Belfast during my FY2 rotation.
Method: An EMIS search was conducted of asthma patients who had been prescribed 12 or more salbutamol inhalers from January 2014-2015. Patients were contacted by telephone or sent a letter to invite them to attend for review of their asthmastarting with those issued the highest quantity of SABA inhalers. They were reviewed by FY2, practice pharmacist and two practice nurses.
Results:
The total number of asthmatic patients prescribed salbutamol in the Year 2014-2015 was 576, with 145 prescribed 12 or more inhalers (25%). The largest quantity issued to a single patient was 44. The table below demonstrates the breakdown of number of inhalers prescribed.
Number of inhalers prescribed Number of patients 12 31
13-19 51
20-29 41
30-39 20
40+ 2
From January-March 2015, 98/145 had been offered appointments or contacted via telephone about their SABA overuse. 46/98 had a review and discussion about their asthma. Those who have failed to attend for review and had been receiving > 1 inhaler per prescription had their prescription reduced to 1 inhaler per script, with a note to make an appointment for review of their usage.
Discussion:
This audit suggested that around ¼ of asthmatics in the practice were poorly controlled. On further review, a large number had failed to attend for an annual asthma review (45%). In those patients reviewed between January and March, their SABA usage had started to reduce over the 3 month period. At review, they were assessed using the BTS/ SIGN guidelines, which cover a spectrum of areas. It was evident that education was very important for them. They were provided with a personal asthma action plan to refer to if they became symptomatic. This audit was presented at the monthly practice meeting in order to update the GP partners and highlight the issue. We would recommend vigilance when prescribing inhalers -those with excessive usage may benefit from education and personal action plans with the goal of reducing avoidable mortality.
INAPPROPRIATE ED ATTENDANCES IN NORTHERN IRELAND: A REVIEW OF ATTENDANCES IN THE BELFAST HEALTH AND SOCIAL CARE TRUST
Editor, Inappropriate attendances (IAs) at Emergency Departments (EDs) may impact on patient safety and flow through the unscheduled care system. These are attendances where care could have been provided safely and more appropriately in other locations, e.g., by a general practitioner (GP) or by selfmanagement. This study aimed to identify the number and type of IAs at EDs in the Belfast Health and Social Care Trust.
Notes of two consecutive days' ED attendances at the Royal Victoria Hospital (RVH) and Mater Hospital (MIH), 11th and 12th January 2015, were reviewed. During these days there were no significant incidents that would have been expected to alter the number or type of attendances. IAs were identified as those where the ED team did not provide any change in management or add to the patient journey or where, although the team may have provided some management, care could have safely been provided in another setting.
There were 646 attendances during the review period. Most were appropriate; 93.5% at the RVH ED and 79% at the MIH ED.
